Insider Trading History of Eichler Kurt M

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Eichler Kurt M since 2009. The trader's CIK number is 1424591. At the time of the last reporting, Eichler Kurt M was the Officer of Spring Bank Pharmaceuticals, Inc.. (stock ticker symbol SBPH). Also see all insider trading activities at Spring Bank Pharmaceuticals, Inc..

Note that in the past Eichler Kurt M also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Mimedx Group, Inc. (MDXG) by Eichler Kurt M

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2010 MDXG 50,493 $49,988 0 $0 0 $0
2009 MDXG 16,666 $7,499 0 $0 0 $0

Yearly summary of insider trading at Spring Bank Pharmaceuticals, Inc. (SBPH) by Eichler Kurt M

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 SBPH 0 $0 40,000 $50,560 0 $0
2017 SBPH 78,123 $1,010,514 0 $0 0 $0
2016 SBPH 55,666 $640,302 0 $0 0 $0


Insider trading activities at 2 companies by Eichler Kurt M:

1. Mimedx Group, Inc. (MDXG)

2. Spring Bank Pharmaceuticals, Inc. (SBPH)

Table 1. Insider trading of Mimedx Group, Inc. (MDXG) by Eichler Kurt M

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2010-12-31 MDXG Buy 50,493 .99 49,988
2009-10-19 MDXG.OB Buy 16,666 .45 7,499

Table 2. Insider trading of Spring Bank Pharmaceuticals, Inc. (SBPH) by Eichler Kurt M

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-12-30 SBPH Sale 40,000 1.26 50,560
2017-06-27 SBPH Buy 76,923 13.00 999,999
2017-02-23 SBPH Buy 1,200 8.76 10,515
2016-11-09 SBPH Buy 7,000 8.69 60,830
2016-09-19 SBPH Buy 1,346 12.50 16,825
2016-09-16 SBPH Buy 650 12.50 8,125
2016-09-14 SBPH Buy 514 12.50 6,425
2016-09-13 SBPH Buy 490 12.50 6,125
2016-08-23 SBPH Buy 3,000 10.73 32,190
2016-08-04 SBPH Buy 1,000 9.79 9,790
2016-05-11 SBPH Buy 41,666 12.00 499,992

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Eichler Kurt M (Officer of Spring Bank Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.